by ASTCT Talks
In this episode of ASTCT Talks, host Daniel Olson, MD, medical oncologist and co-leader of the melanoma, sarcoma, and solid tumor cellular therapy programs at the University of Chicago, is joined...
by Alex Kadhim
Analysis drawing on tumor-infiltrating lymphocyte (TIL) therapy performed at Memorial Sloan Kettering Cancer Center in New York, with collaboration at Weill Cornell Medical College and Stanford...
by Alex Kadhim
A case report from the University of Kansas Medical Center highlights how a documented drug intolerance mislabeled as an allergy can leave a profoundly immunosuppressed cancer patient without...
by Alex Kadhim
Researchers identified ADGRG1 and CD86 as novel markers of tumor-reactive CD4+ T cells in solid tumors, enabling enrichment of neoantigen-specific lymphocytes for functional studies and...
by Alex Kadhim
A pooled analysis in advanced melanoma identifies stem-like and LAG-3-expressing CD8+ T cells, along with tumor-associated tertiary lymphoid structures, as key predictors of durable response to...
by Alex Kadhim
New research identifies a B cell–CD2 costimulatory pathway that enhances adoptive T-cell therapy, improving TIL and CAR-T cell function, metabolism, and tumor control in solid tumors. These...